Search for a clinical trial
Other search option(s)
4 Result(s)
Recruiting trial
= ; Ongoing trial
=
; Terminated trial =
; Funded by an IRDiRC member =
; Study involving ERN members in at least two Member States =
National clinical trial(s)

AUSTRIA
WIEN
ADDRESS: NOT PROVIDED - AT

A Phase 2/3, Multicenter, Randomized, Dose Optimization (Part I), Double-blind (Part II) Study to Compare the Efficacy and Safety of Oral Azacitidine (Oral-Aza, ONUREG®) Plus Best Supportive Care (BSC) Versus Placebo Plus BSC in Participants With IPSS-R Low- or Intermediate-risk Myelodysplastic Syndrome (MDS) - AT
Institution: Information not provided - AT

NETHERLANDS
Utrecht
UTRECHT


PPI Shine Again: Proton pump inhibition for secondary hemochromatosis in hereditary anemia, a phase III placebo controlled randomized cross-over clinical trial
UMC Utrecht - Universitair Medisch Centrum Utrecht
Van Creveldkliniek
Multinational clinical trial(s)

SWITZERLAND
Suisse Romande
ADDRESS: NOT PROVIDED - CH
An open-label, phase II, randomized, pilot study to assess the effect in term of erythroid improvement of deferasirox combined with erythropoietin compared to erythropoietin alone in patients with low- and int-1-risk myelodysplastic syndrome
Institution: Information not provided - CH

UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US